Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells

Ophthalmic Research

Volumn 49, Issue 3, 2013, Pages 139-149

  Xie, Wankun ^a,b,c   Zhao, Min ^a,b   Zhou, Weiyan ^a,b,d   Guo, Lili ^a,b   Huang, Lvzhen ^a,b   Yu, Wenzhen ^a,b   Li, Xiaoxin ^a,b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Integrin linked kinase; Retinal neovascularization; Retinal vascular endothelial cells; Vascular endothelial growth factor

Indexed keywords

INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN 165;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FETUS; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RETINA CELL; RETINA NEOVASCULARIZATION; WESTERN BLOTTING; AMNION; ANGIOGENESIS; ANGIOGENESIS ASSAY; CELL ADHESION ASSAY; CELL COUNTING; CELL VIABILITY; HUMAN; IN VITRO STUDY; MTT ASSAY; PROTEIN TARGETING; RNA ISOLATION;

BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871189758     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000345070     Document Type: Article

References (32)

1. Fulton AB, Hansen RM, Moskowitz A, Akula JD: The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 2009; 28: 452-482.
2. Wirostko B, Wong TY, Simó R: Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 2008; 27: 608-621.
3. Ding XY, Patel M, Chan CC: Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.
4. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME: Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27: 331-371.
5. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
6. Takahashi T, Yamaguchi S, Chida K, Shibuya M: A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-[gamma] and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20: 2768-2778.
7. Shalaby F, Ho J, Stanford WL, et al: A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997; 89: 981-990.
8. Folkman J: Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273-286.
9. Mitra SK, Hanson DA, Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56-68.
10. Boulter E, Van Obberghen-Schilling E: Integrin- linked kinase and its partners: a modular platform regulating cell-matrix adhesion dynamics and cytoskeletal organization. Eur J Cell Biol 2006; 85: 255-263.
11. Guo L, Yu W, Li X, Zhao G, He P: Targeting of integrin-linked kinase with a small interfering RNA inhibits endothelial cell migration, proliferation and tube formation in vitro. Ophthal Res 2009; 42: 213-220.
12. Guo L, Yu W, Li X, et al: Targeting of integrin- linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy. Exp Eye Res 2008; 87: 551-560.
13. Huang L, Xu YS, Yu W, et al: Effect of Robo1 on retinal pigment epithelium cells and experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2010; 51: 3193-3204.
14. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE: RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res 2005; 11: 3433-3438.
15. Wong RPC, Ng P, Dedhar S, Li G: The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther 2007; 6: 1692-1700.
16. Huang LZ, Yu WZ, Li XX, et al: Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. Mol Vision 2009; 15: 1057-1069.
17. Qazi Y, Maddula S, Ambati BK: Mediators of ocular angiogenesis. J Genet 2009; 88: 495-515.
18. Gariano RF, Gardner TW: Retinal angiogenesis in development and disease. Nature 2004; 438: 960-966.
19. Witmer AN, Vrensen G, Van Noorden CJF, Schlingemann RO: Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1-29.
20. Gao J, Zhu J, Li H-Y, Pan X-Y, Jiang R, Chen J-X: Small interfering RNA targeting integrin- linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Int J Biochem Cell Biol 2011; 43: 1294-1304.
21. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
22. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC: Prospects of RNA interference therapy for cancer. Gene Ther 2005; 13: 464-477.
23. Ferrara N, Kerbel RS: Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974.
24. Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV: Mechanisms of integrin vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 2007; 101: 570-580.
25. Somanath P, Malinin N, Byzova T: Cooperation between integrin αvβ3 and VEGFR2 in angiogenesis. Angiogenesis 2009; 12: 177-185.
26. Dimitropoulos K, Giannopoulou E, Argyriou AA, et al: The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins. Anticancer Res 2010; 30: 4987-4992.
27. Byrne AM, Bouchier-Hayes DJ, Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005; 9: 777-794.
28. Yu X, Zhu J, Mi M, Chen W, Pan Q, Wei M: Anti-angiogenic genistein inhibits VEGFinduced endothelial cell activation by decreasing PTK activity and MAPK activation. Med Oncol 2012; 29: 349-357.
29. Ramjaun AR, Hodivala-Dilke K: The role of cell adhesion pathways in angiogenesis. Int J Biochem Cell Biol 2009; 41: 521-530.
30. McDonald PC, Fielding AB, Dedhar S: Integrin- linked kinase - essential roles in physiology and cancer biology. J Cell Sci 2008; 121: 3121-3132.
31. Ishii T, Uto T, Mori K, Fujikawa R: Integrinlinked kinase is involved in lactoferrin-induced anchorage-independent cell growth and survival in PC12 cells. Life Sci 2009; 84: 530-536.
32. Comoglio PM, Boccaccio C, Trusolino L: Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 2003; 15: 565-571.